QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
NASDAQ:SRDX

Surmodics - SRDX Stock Forecast, Price & News

$35.84
+0.08 (+0.22%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$33.51
$36.94
50-Day Range
$29.44
$36.41
52-Week Range
$28.27
$50.85
Volume
60,064 shs
Average Volume
41,536 shs
Market Capitalization
$503.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$58.00

Surmodics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
61.8% Upside
$58.00 Price Target
Short Interest
Healthy
2.25% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.52
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$335,340 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.37) to ($0.98) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

Medical Sector

221st out of 1,027 stocks

Surgical & Medical Instruments Industry

24th out of 101 stocks

SRDX stock logo

About Surmodics (NASDAQ:SRDX) Stock

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Receive SRDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surmodics and its competitors with MarketBeat's FREE daily newsletter.

SRDX Stock News Headlines

Surmodics (SRDX) Q4 Earnings and Revenues Top Estimates
Surmodics, Inc.
Surmodics Reports Third Quarter Fiscal 2022 Results
Surmodics SRDX Trading Report
See More Headlines
Receive SRDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surmodics and its competitors with MarketBeat's FREE daily newsletter.

SRDX Company Calendar

Last Earnings
11/09/2022
Today
12/07/2022
Next Earnings (Estimated)
2/02/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:SRDX
CUSIP
86887310
Employees
389
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$58.00
High Stock Price Forecast
$58.00
Low Stock Price Forecast
$58.00
Forecasted Upside/Downside
+61.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-27,270,000.00
Pretax Margin
-22.50%

Debt

Sales & Book Value

Annual Sales
$99.95 million
Book Value
$7.75 per share

Miscellaneous

Free Float
13,099,000
Market Cap
$503.19 million
Optionable
Optionable
Beta
0.97

Social Links


Key Executives

  • Mr. Gary R. MaharajMr. Gary R. Maharaj (Age 59)
    CEO, Pres & Director
    Comp: $1.29M
  • Mr. Timothy J. Arens (Age 55)
    Sr. VP of Fin. & Information Technology and CFO
    Comp: $572k
  • Mr. Gordon S. Weber (Age 59)
    Sr. VP of Legal, Gen. Counsel & Sec.
    Comp: $573.67k
  • Mr. Joseph J. StichMr. Joseph J. Stich (Age 57)
    Sr. VP of HR & Pres of In Vitro Diagnostics
    Comp: $570.92k
  • Ms. Teryl L. W. Sides (Age 52)
    Sr. VP & Pres of Vascular Interventions
    Comp: $638.67k
  • Mr. John D. Manders (Age 41)
    Corp. Controller, VP of Fin. & Principal Accounting Officer
  • Mr. Charles W. OlsonMr. Charles W. Olson (Age 58)
    Sr. VP & Pres of Medical Device Coatings
  • Mr. Gregg S. Sutton (Age 62)
    VP of R&D - Medical Devices













SRDX Stock - Frequently Asked Questions

Should I buy or sell Surmodics stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surmodics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SRDX shares.
View SRDX analyst ratings
or view top-rated stocks.

What is Surmodics' stock price forecast for 2023?

1 Wall Street analysts have issued 1 year price objectives for Surmodics' shares. Their SRDX share price forecasts range from $58.00 to $58.00. On average, they predict the company's stock price to reach $58.00 in the next twelve months. This suggests a possible upside of 61.8% from the stock's current price.
View analysts price targets for SRDX
or view top-rated stocks among Wall Street analysts.

How have SRDX shares performed in 2022?

Surmodics' stock was trading at $48.15 at the start of the year. Since then, SRDX shares have decreased by 25.6% and is now trading at $35.84.
View the best growth stocks for 2022 here
.

When is Surmodics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our SRDX earnings forecast
.

How were Surmodics' earnings last quarter?

Surmodics, Inc. (NASDAQ:SRDX) issued its quarterly earnings data on Wednesday, November, 9th. The company reported ($0.26) earnings per share for the quarter, topping analysts' consensus estimates of ($0.38) by $0.12. The firm had revenue of $25.99 million for the quarter, compared to analyst estimates of $24.84 million. Surmodics had a negative net margin of 27.29% and a negative trailing twelve-month return on equity of 10.59%.

What guidance has Surmodics issued on next quarter's earnings?

Surmodics updated its FY 2023 earnings guidance on Wednesday, November, 9th. The company provided EPS guidance of -$2.54--$2.14 for the period, compared to the consensus estimate of -$0.77. The company issued revenue guidance of $103.00 million-$107.00 million, compared to the consensus revenue estimate of $121.56 million.

What is Gary Maharaj's approval rating as Surmodics' CEO?

8 employees have rated Surmodics Chief Executive Officer Gary Maharaj on Glassdoor.com. Gary Maharaj has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Surmodics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surmodics investors own include Gilead Sciences (GILD), Netflix (NFLX), Exelixis (EXEL), Intel (INTC), NVIDIA (NVDA), Tandem Diabetes Care (TNDM), uniQure (QURE), Sangamo Therapeutics (SGMO), Abbott Laboratories (ABT) and Dynavax Technologies (DVAX).

What is Surmodics' stock symbol?

Surmodics trades on the NASDAQ under the ticker symbol "SRDX."

Who are Surmodics' major shareholders?

Surmodics' stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (16.22%), Trigran Investments Inc. (16.21%), Vanguard Group Inc. (6.97%), Renaissance Technologies LLC (4.58%), State Street Corp (3.63%) and Dimensional Fund Advisors LP (3.22%). Insiders that own company stock include Charles W Olson, Charles W Olson, David Dantzker, Gary R Maharaj, Gary R Maharaj, John D Manders, Jose H Bedoya, Jose H Bedoya, Joseph J Stich, Joseph J Stich and Ronald B Sr Kalich Sr.
View institutional ownership trends
.

How do I buy shares of Surmodics?

Shares of SRDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surmodics' stock price today?

One share of SRDX stock can currently be purchased for approximately $35.84.

How much money does Surmodics make?

Surmodics (NASDAQ:SRDX) has a market capitalization of $503.19 million and generates $99.95 million in revenue each year. The company earns $-27,270,000.00 in net income (profit) each year or ($1.96) on an earnings per share basis.

How many employees does Surmodics have?

The company employs 389 workers across the globe.

How can I contact Surmodics?

Surmodics' mailing address is 9924 WEST 74TH STREET, EDEN PRAIRIE MN, 55344. The official website for the company is www.surmodics.com. The company can be reached via phone at (952) 500-7000, via email at ir@surmodics.com, or via fax at 952-500-7001.

This page (NASDAQ:SRDX) was last updated on 12/7/2022 by MarketBeat.com Staff